久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

You are here: Industry Insights > gastrointestinal cancer

News List

I-Mab Appoints International Gastrointestinal Oncology Expert Dr. Andrew Zhu to its Scientific Advisory Board prnasia
June 22, 2021
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the appointment of Andrew Zhu, MD, PhD, to the Company's Scientific Advisory Board.
Oncolytics Biotech, Roche, AIO Initiate Gastrointestinal Cancer Trial americanpharmaceuticalreview
November 05, 2020
Oncolytics Biotech? announced a new multi-indication gastrointestinal (GI) cancer study to be managed by AIO. The phase 1/2 trial, known as GOBLET, will investigate the use of pelareorep, in combination with Roche's anti-PD-L1 checkpoint inhibitor ...
Keytruda cuts risk of death by 31% in esophageal cancer trial pharmaphorum
January 16, 2019
MSD’s Keytruda has cut the risk of death by 31% in patients with esophageal or esophagogastric junction carcinoma or adenocarcinoma who progressed after standard therapy.